3rd Quarter - Report

INOVIO PHARMACEUTICALS, INC. for INOVIO PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Next Generation COVID-19 vaccines and boosters; Issues related to Accelerated Approval reforms and accelerated approval pathway at FDA and decentralized trials; Issues related to Recurrent Respiratory Papillomatosis (RRP), an HPV associated disease; DNA Medicines Platform Technology awareness; Issues related to medical devices and cybersecurity issues; Issues related to Transitional Coverages of Emerging Technologies (TCET) and medical devices; Issues related to funding for Advanced Research Projects Agency for Health

LobbyistCovered position, as disclosed
COOKAB HASHEMI —

Contacted: Defense, Dept of (DOD); White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.